Insider · CIK 0001811030
Uri Weinberg
Files at NVCR (NovoCure Ltd). First filing Mar 3, 2026, latest Mar 5, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NVCR: NovoCure Ltd
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 39Weak | NovoCure Ltd | $85k 6,412 shares | -2% | +34% from low-37% from high | |
| 41Moderate | NovoCure Ltd | $147k 10,733 shares | -5% | +36% from low-36% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 3, 2025 | NVCR NovoCure Limited | 268 0.00% of outstanding | $5,071 | Mar 3, 2025 | $87k |
| Feb 28, 2025 | NVCR NovoCure Limited | 4,637 0.00% of outstanding | $87k | Feb 28, 2025 | none |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +50,125 | $0.00 | $0 | 273,602 | Mar 5, 2026 |
| Mar 4, 2026 | NVCR NovoCure Ltd | SOpen-market sale Ordinary Shares | -6,412 | $13.31 | $85k | 267,190 | Mar 5, 2026 |
| Mar 3, 2026 | NVCR NovoCure Ltd | AGrant or award Stock Option (Right to Buy)derivative | +73,340 | $0.00 | $0 | 73,340 | Mar 5, 2026 |
| Feb 27, 2026 | NVCR NovoCure Ltd | SOpen-market sale Ordinary Shares | -7,461 | $13.84 | $103k | 213,757 | Mar 3, 2026 |
| Feb 28, 2026 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +12,992 | $0.00 | $0 | 226,749 | Mar 3, 2026 |
| Mar 2, 2026 | NVCR NovoCure Ltd | SOpen-market sale Ordinary Shares | -3,272 | $13.33 | $44k | 223,477 | Mar 3, 2026 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.